David R. Anderson,Robert A. Volkmann,Gregg F. Keaney,Steven C. Leiser,Sam Malekiani,Timothy Piser
申请号：
US16678806
公开号：
US10752633B2
申请日:
2019.11.08
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided is 5-(3-chloro-4-fluorophenyl)-7-cyclopropyl-3-(2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one and pharmaceutically acceptable salts thereof, and their uses in the treatment of psychiatric, neurological, and neurodevelopmental disorders, as well as diseases of the nervous system.
